Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
What Mood Symptoms may be most Difficult to Rate?
1
x
$
30.00
View Cart
Checkout
Home
Cara L. Alfaro, PharmD: Emerging Role of Drug Interaction Studies in Drug Development:The Good, the Bad, and the Unknown
“What Mood Symptoms may be most Difficult to Rate?” has been added to your cart.
View cart
Cara L. Alfaro, PharmD: Emerging Role of Drug Interaction Studies in Drug Development:The Good, the Bad, and the Unknown
$
30.00
Cara L. Alfaro, PharmD: Emerging Role of Drug Interaction Studies in Drug Development:The Good, the Bad, and the Unknown quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 35 No. 4 Articles
Tags:
cara-l-alfaro
,
cytochrome-p450
,
drug-development
,
food-and-drug-administration
,
medworks-media
,
new-dru-g-application
,
psychopharmacology-bulletin
,
regulatory-guidance
Description
Description
Cara L. Alfaro, PharmD
DRUG INTERACTIONS
Emerging Role of Drug Interaction Studies in Drug Development:The Good, the Bad, and the Unknown
Cara L. Alfaro, PharmD
Related products
Ramelteon for Insomnia Related to (ADHD) by Rachel E. Fargason
$
30.00
Add to cart
Details
Schizophrenia Rating Scales Critical Review by Takefumi Suzuki
$
30.00
Add to cart
Details
Quetiapine XR Negative Clinical Trials Report by Gang Wang
$
30.00
Add to cart
Details
Long Acting Risperidone in an Adolescent – Mustafa Deniz Tutkunkardas
$
30.00
Add to cart
Details
Page load link
Go to Top
